On 24 May 2022, the European Commission published (EU) Regulation 2022/808 amending the approval period for bispyribac.
According to the regulation, the approval period of bispyribac is revised to July 31, 2022. These regulations shall take effect twenty days from the date of promulgation.
据欧盟官方公报消息,2022年5月24日,欧盟委员会发布(EU)2022/808号条例,修订双草醚(bispyribac)的批准期限。
据条例,双草醚的批准期限修订为2022年7月31日。本条例自发布之日起第二十天生效。